Mediwound reports fourth quarter and full year 2023 financial results and provides company update

$19 million revenue in 2023; $24 million projected revenue in 2024 nexobrid ® commercially launched in u.s., japan, india potential blockbuster escharex ® to begin phase iii in the second half of 2024 $42 million cash runway through profitability
MDWD Ratings Summary
MDWD Quant Ranking